Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis

A. Antczak, P. Gorski (Lodz, Poland)

Source: Annual Congress 2003 - Asthma and rhinitis
Session: Asthma and rhinitis
Session type: Thematic Poster Session
Number: 749
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Antczak, P. Gorski (Lodz, Poland). Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis. Eur Respir J 2003; 22: Suppl. 45, 749

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytokine levels in nasal biopsies in allergic and non-allergic rhinitis and asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010

Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001

Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

microRNA levels in nasal biopsies in allergic and non-allergic rhinitis and asthma
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011

Allergic rhinitis : zafirlukast reduces eosinophil number in nasal lavage fluid
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002

Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016


Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

The ultrastructure of nasal mucosa in asthmatic children with and without allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 398s
Year: 2005

Influence of RUZAM on symptoms score and eosinophils count in nasal lavage fluid of patients with perennial allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005

Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

Evaluation bronchial hyperresponsivness in patients with persistent allergic rhinitis
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Induced sputum eosinophils, bronchial reactivity and cough sensitivity in allergic rhinitis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 583s
Year: 2005

IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 735s
Year: 2005

Increased levels of RANTES in induced sputum of chronic asthma but not in seasonal grass pollen-induced rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 476s
Year: 2003

Eotaxins expression in nasal mucosa in patients with asthma and seasonal rhinitis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010

Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009